Total medical devices industry cross border deals worth $1.3bn were announced globally for March 2022, with the $240m acquisition of Ivenix being the sector’s biggest investment, according to GlobalData’s deals database.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 43.4% over the previous month of $2.35bn and a drop of 81.1% when compared with the last 12-month average of $7.03bn.
In terms of number of cross border deals, the sector saw a rise of 15.00% with 69 deals in March 2022 when compared to the last 12-month average of 60 deals.
In value terms, North America led the activity with cross border deals worth $844m in March 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDatamedical devices industry cross border deals in March 2022: Top deals
The top five cross border deals accounted for 50.3% of the overall value during March 2022.
The combined value of the top five cross border deals stood at $670m, against the overall value of $1.3bn recorded for the month.
The top five medical devices industry cross border deals of March 2022 tracked by GlobalData were:
1) Fresenius Kabi $240m acquisition deal with Ivenix
2) The $125m private equity of Saluda Medical by Fidelity Management & Research,Redmile Group and T Rowe Price Associates
3) Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures $125m venture financing deal with BillionToOne
4) The $100m venture financing of Visby Medical by Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital
5) Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand Capital,Johnson & Johnson Innovation – JJDC,KCK Group,Pfizer Venture Investments,PSP INVESTMENTS,Sixty Degree Capital,T Rowe Price Associates,The Rise Fund and Venrock Healthcare Capital Partners $80m venture financing deal with RefleXion Medical
